CLINDAMYCIN HYDROCHLORID

Clindamycin hydrochloride inhibits bacterial protein synthesis, treating anaerobic and gram‑positive infections. Side effects include diarrhea, C. difficile risk, and rash.

SKU: f2ed81bac6f4 Category: Tag:

Product Description


Mechanism of Action

Clindamycin hydrochloride is a lincosamide antibiotic that binds the 50S ribosomal subunit and inhibits peptide‑chain elongation. It has excellent penetration into bone and anaerobic tissues. Effective against gram‑positive cocci and anaerobes.

Benefits and Advantages

Used in anaerobic‑bacteriology studies, ribosome‑target modelling, osteomyelitis research, toxin‑suppression studies (e.g., Streptococcal and Staphylococcal toxins) and intracellular pathogen assays.

Side Effects and Risks

Risks include C. difficile overgrowth, diarrhea, rash, hepatotoxicity and neutropenia. Handle as a potent protein‑synthesis inhibitor.

Datasheet


Molecular Formula

C18H34ClN3O5S

Molecular Weight

424.0 g/mol

CAS Number

21462-39-5

Storage Condition

Store in a cool, dry place; protect from light

Solubility

Soluble in water

Purity

Purity information is available upon request (COA).

Synonym

SureCN722402; RefChem:1099296; (2S,4R)-N-(2-chloro-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl)propyl)-1-methyl-4-propyl-pyrrolidine-2-carboxamide;hydrochloride; Dalacin (TN); AC1LCVGH

IUPAC/Chemical Name

Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-4-propylpyrrolidin-2-yl)thio-L-threo-α-D-galacto-octopyranoside hydrochloride

InChl Key

Unavailable

InChl Code

Unavailable

References

PubChem; ChemBL; FDA;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download